Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia

CONTEXTMalignant hyperthermia may follow exposure to trace quantities of inhalational anaesthetics. In susceptible patients, the complete avoidance of these triggers is advised when possible; however, failing this, it is essential to washout or purge the anaesthesia machine of residual inhalational...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of anaesthesiology 2012-05, Vol.29 (5), p.229-234
Hauptverfasser: Shanahan, Hiliary, O’Donoghue, Rory, O’Kelly, Patrick, Synnott, Aidan, O’Rourke, James
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 234
container_issue 5
container_start_page 229
container_title European journal of anaesthesiology
container_volume 29
creator Shanahan, Hiliary
O’Donoghue, Rory
O’Kelly, Patrick
Synnott, Aidan
O’Rourke, James
description CONTEXTMalignant hyperthermia may follow exposure to trace quantities of inhalational anaesthetics. In susceptible patients, the complete avoidance of these triggers is advised when possible; however, failing this, it is essential to washout or purge the anaesthesia machine of residual inhalational anaesthetics. OBJECTIVEThis study examined the washout profile of sevoflurane from the Drager Fabius CE and the Drager Zeus machines. DESIGNThe washout profile of sevoflurane was measured from the Fabius CE and Zeus anaesthesia machines following a standard period of exposure. The disposable tubing, CO2 absorber and other components of each machine were then replaced to examine their impact on the retention of sevoflurane. The effect of autoclaving the ventilator diaphragm and non-disposable ventilator tube or substituting for a new diaphragm and ventilation tube were examined in later parts of this study. SETTINGUniversity teaching hospital. MAIN OUTCOME MEASURETime taken to reach 5 parts per million of sevoflurane when machines underwent standard washout with fresh gas flush. RESULTSThe concentration of sevoflurane reached 5 parts per million in the Fabius CE machines after an mean (SD) of 140 min (46) at a fresh gas flow (FGF) of 10 l min. The time taken for sevoflurane to reach 5 parts per million was significantly reduced when the ventilator diaphragm and non-disposable tube were replaced with either new or autoclaved components [14 or 22 min, respectively (P = 0.017, P = 0.031)]. The concentration of sevoflurane reached 5 parts per million in the Zeus machines after an mean (SD) of 85 min (6) at a fresh gas flow of 10 l min. When the fresh gas flow was increased to 18 l min (the maximum allowable), the time to reach 5 parts per million was reduced to 16 min. CONCLUSIONWhen preparing the Fabius CE for the malignant hyperthermia susceptible patient, remove the vaporiser, replace the disposable tubing, the reservoir bag and the CO2 absorber. Replace the ventilator diaphragm and non-disposable ventilator tube with new or autoclaved components and flush the machine at 10 l min for at least 36 min. When preparing the Zeus, remove the vaporiser, replace the disposable tubing, the reservoir bag and CO2 absorber and flush at a fresh gas flow of 10 l min for at least 90 min. In both the Fabius and Zeus, continue at a fresh gas flow of 10 l min for the duration of the operation.
doi_str_mv 10.1097/EJA.0b013e328351b521
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1008825575</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1008825575</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4021-fd0f8b6f551e6a72dcc50e9b76019fbea4d3612ed4985f946f9457bb0eccbf93</originalsourceid><addsrcrecordid>eNp9kElLBDEQhYMoOi7_QCRHLzNW0p1ejjKOG4Ie5uSlSdIVO9qbSRoR_7yRUQ8ePBQpiu-9PB4hxwwWDMr8bHV7vgAFLMGEF4lgSnC2RWYsycScJ2m2TWbA4w6ciT2y7_0zAAgGbJfscZ4URQ5iRj4eHI7SyWCHng6GhgbphZNP6OilVHbydLmisq9_jo8YT7KX6CMZrKad1I3t0VMzODpGH-yDp37yGsdgVYs0DBFq7VMv-0Cb9xFdlLrOykOyY2Tr8ej7PSDry9V6eT2_u7-6WZ7fzXUaw89NDaZQmRGCYSZzXmstAEuVZ8BKo1CmdZIxjnVaFsKUaRZH5EoBaq1MmRyQ043t6IbXKQavOhvTta3scZh8xQCKgguRi4imG1S7wXuHphqd7aR7j1D11XoVW6_-th5lJ98_TKrD-lf0U3MEig3wNrQBnX9ppzd0VYOyDc3_3p85DJI4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1008825575</pqid></control><display><type>article</type><title>Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Shanahan, Hiliary ; O’Donoghue, Rory ; O’Kelly, Patrick ; Synnott, Aidan ; O’Rourke, James</creator><creatorcontrib>Shanahan, Hiliary ; O’Donoghue, Rory ; O’Kelly, Patrick ; Synnott, Aidan ; O’Rourke, James</creatorcontrib><description>CONTEXTMalignant hyperthermia may follow exposure to trace quantities of inhalational anaesthetics. In susceptible patients, the complete avoidance of these triggers is advised when possible; however, failing this, it is essential to washout or purge the anaesthesia machine of residual inhalational anaesthetics. OBJECTIVEThis study examined the washout profile of sevoflurane from the Drager Fabius CE and the Drager Zeus machines. DESIGNThe washout profile of sevoflurane was measured from the Fabius CE and Zeus anaesthesia machines following a standard period of exposure. The disposable tubing, CO2 absorber and other components of each machine were then replaced to examine their impact on the retention of sevoflurane. The effect of autoclaving the ventilator diaphragm and non-disposable ventilator tube or substituting for a new diaphragm and ventilation tube were examined in later parts of this study. SETTINGUniversity teaching hospital. MAIN OUTCOME MEASURETime taken to reach 5 parts per million of sevoflurane when machines underwent standard washout with fresh gas flush. RESULTSThe concentration of sevoflurane reached 5 parts per million in the Fabius CE machines after an mean (SD) of 140 min (46) at a fresh gas flow (FGF) of 10 l min. The time taken for sevoflurane to reach 5 parts per million was significantly reduced when the ventilator diaphragm and non-disposable tube were replaced with either new or autoclaved components [14 or 22 min, respectively (P = 0.017, P = 0.031)]. The concentration of sevoflurane reached 5 parts per million in the Zeus machines after an mean (SD) of 85 min (6) at a fresh gas flow of 10 l min. When the fresh gas flow was increased to 18 l min (the maximum allowable), the time to reach 5 parts per million was reduced to 16 min. CONCLUSIONWhen preparing the Fabius CE for the malignant hyperthermia susceptible patient, remove the vaporiser, replace the disposable tubing, the reservoir bag and the CO2 absorber. Replace the ventilator diaphragm and non-disposable ventilator tube with new or autoclaved components and flush the machine at 10 l min for at least 36 min. When preparing the Zeus, remove the vaporiser, replace the disposable tubing, the reservoir bag and CO2 absorber and flush at a fresh gas flow of 10 l min for at least 90 min. In both the Fabius and Zeus, continue at a fresh gas flow of 10 l min for the duration of the operation.</description><identifier>ISSN: 0265-0215</identifier><identifier>EISSN: 1365-2346</identifier><identifier>DOI: 10.1097/EJA.0b013e328351b521</identifier><identifier>PMID: 22388705</identifier><language>eng</language><publisher>England: European Society of Anaesthesiology</publisher><subject>Anesthesia, Inhalation - adverse effects ; Anesthesia, Inhalation - instrumentation ; Anesthetics, Inhalation - adverse effects ; Decontamination - methods ; Disease Susceptibility ; Disposable Equipment ; Equipment Contamination - prevention &amp; control ; Equipment Design ; Hospitals, University ; Hot Temperature ; Humans ; Ireland ; Malignant Hyperthermia - etiology ; Malignant Hyperthermia - prevention &amp; control ; Methyl Ethers - adverse effects ; Respiration, Artificial - adverse effects ; Respiration, Artificial - instrumentation ; Risk Assessment ; Risk Factors ; Sterilization - methods ; Time Factors</subject><ispartof>European journal of anaesthesiology, 2012-05, Vol.29 (5), p.229-234</ispartof><rights>2012 European Society of Anaesthesiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4021-fd0f8b6f551e6a72dcc50e9b76019fbea4d3612ed4985f946f9457bb0eccbf93</citedby><cites>FETCH-LOGICAL-c4021-fd0f8b6f551e6a72dcc50e9b76019fbea4d3612ed4985f946f9457bb0eccbf93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22388705$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shanahan, Hiliary</creatorcontrib><creatorcontrib>O’Donoghue, Rory</creatorcontrib><creatorcontrib>O’Kelly, Patrick</creatorcontrib><creatorcontrib>Synnott, Aidan</creatorcontrib><creatorcontrib>O’Rourke, James</creatorcontrib><title>Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia</title><title>European journal of anaesthesiology</title><addtitle>Eur J Anaesthesiol</addtitle><description>CONTEXTMalignant hyperthermia may follow exposure to trace quantities of inhalational anaesthetics. In susceptible patients, the complete avoidance of these triggers is advised when possible; however, failing this, it is essential to washout or purge the anaesthesia machine of residual inhalational anaesthetics. OBJECTIVEThis study examined the washout profile of sevoflurane from the Drager Fabius CE and the Drager Zeus machines. DESIGNThe washout profile of sevoflurane was measured from the Fabius CE and Zeus anaesthesia machines following a standard period of exposure. The disposable tubing, CO2 absorber and other components of each machine were then replaced to examine their impact on the retention of sevoflurane. The effect of autoclaving the ventilator diaphragm and non-disposable ventilator tube or substituting for a new diaphragm and ventilation tube were examined in later parts of this study. SETTINGUniversity teaching hospital. MAIN OUTCOME MEASURETime taken to reach 5 parts per million of sevoflurane when machines underwent standard washout with fresh gas flush. RESULTSThe concentration of sevoflurane reached 5 parts per million in the Fabius CE machines after an mean (SD) of 140 min (46) at a fresh gas flow (FGF) of 10 l min. The time taken for sevoflurane to reach 5 parts per million was significantly reduced when the ventilator diaphragm and non-disposable tube were replaced with either new or autoclaved components [14 or 22 min, respectively (P = 0.017, P = 0.031)]. The concentration of sevoflurane reached 5 parts per million in the Zeus machines after an mean (SD) of 85 min (6) at a fresh gas flow of 10 l min. When the fresh gas flow was increased to 18 l min (the maximum allowable), the time to reach 5 parts per million was reduced to 16 min. CONCLUSIONWhen preparing the Fabius CE for the malignant hyperthermia susceptible patient, remove the vaporiser, replace the disposable tubing, the reservoir bag and the CO2 absorber. Replace the ventilator diaphragm and non-disposable ventilator tube with new or autoclaved components and flush the machine at 10 l min for at least 36 min. When preparing the Zeus, remove the vaporiser, replace the disposable tubing, the reservoir bag and CO2 absorber and flush at a fresh gas flow of 10 l min for at least 90 min. In both the Fabius and Zeus, continue at a fresh gas flow of 10 l min for the duration of the operation.</description><subject>Anesthesia, Inhalation - adverse effects</subject><subject>Anesthesia, Inhalation - instrumentation</subject><subject>Anesthetics, Inhalation - adverse effects</subject><subject>Decontamination - methods</subject><subject>Disease Susceptibility</subject><subject>Disposable Equipment</subject><subject>Equipment Contamination - prevention &amp; control</subject><subject>Equipment Design</subject><subject>Hospitals, University</subject><subject>Hot Temperature</subject><subject>Humans</subject><subject>Ireland</subject><subject>Malignant Hyperthermia - etiology</subject><subject>Malignant Hyperthermia - prevention &amp; control</subject><subject>Methyl Ethers - adverse effects</subject><subject>Respiration, Artificial - adverse effects</subject><subject>Respiration, Artificial - instrumentation</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Sterilization - methods</subject><subject>Time Factors</subject><issn>0265-0215</issn><issn>1365-2346</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kElLBDEQhYMoOi7_QCRHLzNW0p1ejjKOG4Ie5uSlSdIVO9qbSRoR_7yRUQ8ePBQpiu-9PB4hxwwWDMr8bHV7vgAFLMGEF4lgSnC2RWYsycScJ2m2TWbA4w6ciT2y7_0zAAgGbJfscZ4URQ5iRj4eHI7SyWCHng6GhgbphZNP6OilVHbydLmisq9_jo8YT7KX6CMZrKad1I3t0VMzODpGH-yDp37yGsdgVYs0DBFq7VMv-0Cb9xFdlLrOykOyY2Tr8ej7PSDry9V6eT2_u7-6WZ7fzXUaw89NDaZQmRGCYSZzXmstAEuVZ8BKo1CmdZIxjnVaFsKUaRZH5EoBaq1MmRyQ043t6IbXKQavOhvTta3scZh8xQCKgguRi4imG1S7wXuHphqd7aR7j1D11XoVW6_-th5lJ98_TKrD-lf0U3MEig3wNrQBnX9ppzd0VYOyDc3_3p85DJI4</recordid><startdate>201205</startdate><enddate>201205</enddate><creator>Shanahan, Hiliary</creator><creator>O’Donoghue, Rory</creator><creator>O’Kelly, Patrick</creator><creator>Synnott, Aidan</creator><creator>O’Rourke, James</creator><general>European Society of Anaesthesiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201205</creationdate><title>Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia</title><author>Shanahan, Hiliary ; O’Donoghue, Rory ; O’Kelly, Patrick ; Synnott, Aidan ; O’Rourke, James</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4021-fd0f8b6f551e6a72dcc50e9b76019fbea4d3612ed4985f946f9457bb0eccbf93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Anesthesia, Inhalation - adverse effects</topic><topic>Anesthesia, Inhalation - instrumentation</topic><topic>Anesthetics, Inhalation - adverse effects</topic><topic>Decontamination - methods</topic><topic>Disease Susceptibility</topic><topic>Disposable Equipment</topic><topic>Equipment Contamination - prevention &amp; control</topic><topic>Equipment Design</topic><topic>Hospitals, University</topic><topic>Hot Temperature</topic><topic>Humans</topic><topic>Ireland</topic><topic>Malignant Hyperthermia - etiology</topic><topic>Malignant Hyperthermia - prevention &amp; control</topic><topic>Methyl Ethers - adverse effects</topic><topic>Respiration, Artificial - adverse effects</topic><topic>Respiration, Artificial - instrumentation</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Sterilization - methods</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shanahan, Hiliary</creatorcontrib><creatorcontrib>O’Donoghue, Rory</creatorcontrib><creatorcontrib>O’Kelly, Patrick</creatorcontrib><creatorcontrib>Synnott, Aidan</creatorcontrib><creatorcontrib>O’Rourke, James</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of anaesthesiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shanahan, Hiliary</au><au>O’Donoghue, Rory</au><au>O’Kelly, Patrick</au><au>Synnott, Aidan</au><au>O’Rourke, James</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia</atitle><jtitle>European journal of anaesthesiology</jtitle><addtitle>Eur J Anaesthesiol</addtitle><date>2012-05</date><risdate>2012</risdate><volume>29</volume><issue>5</issue><spage>229</spage><epage>234</epage><pages>229-234</pages><issn>0265-0215</issn><eissn>1365-2346</eissn><abstract>CONTEXTMalignant hyperthermia may follow exposure to trace quantities of inhalational anaesthetics. In susceptible patients, the complete avoidance of these triggers is advised when possible; however, failing this, it is essential to washout or purge the anaesthesia machine of residual inhalational anaesthetics. OBJECTIVEThis study examined the washout profile of sevoflurane from the Drager Fabius CE and the Drager Zeus machines. DESIGNThe washout profile of sevoflurane was measured from the Fabius CE and Zeus anaesthesia machines following a standard period of exposure. The disposable tubing, CO2 absorber and other components of each machine were then replaced to examine their impact on the retention of sevoflurane. The effect of autoclaving the ventilator diaphragm and non-disposable ventilator tube or substituting for a new diaphragm and ventilation tube were examined in later parts of this study. SETTINGUniversity teaching hospital. MAIN OUTCOME MEASURETime taken to reach 5 parts per million of sevoflurane when machines underwent standard washout with fresh gas flush. RESULTSThe concentration of sevoflurane reached 5 parts per million in the Fabius CE machines after an mean (SD) of 140 min (46) at a fresh gas flow (FGF) of 10 l min. The time taken for sevoflurane to reach 5 parts per million was significantly reduced when the ventilator diaphragm and non-disposable tube were replaced with either new or autoclaved components [14 or 22 min, respectively (P = 0.017, P = 0.031)]. The concentration of sevoflurane reached 5 parts per million in the Zeus machines after an mean (SD) of 85 min (6) at a fresh gas flow of 10 l min. When the fresh gas flow was increased to 18 l min (the maximum allowable), the time to reach 5 parts per million was reduced to 16 min. CONCLUSIONWhen preparing the Fabius CE for the malignant hyperthermia susceptible patient, remove the vaporiser, replace the disposable tubing, the reservoir bag and the CO2 absorber. Replace the ventilator diaphragm and non-disposable ventilator tube with new or autoclaved components and flush the machine at 10 l min for at least 36 min. When preparing the Zeus, remove the vaporiser, replace the disposable tubing, the reservoir bag and CO2 absorber and flush at a fresh gas flow of 10 l min for at least 90 min. In both the Fabius and Zeus, continue at a fresh gas flow of 10 l min for the duration of the operation.</abstract><cop>England</cop><pub>European Society of Anaesthesiology</pub><pmid>22388705</pmid><doi>10.1097/EJA.0b013e328351b521</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0265-0215
ispartof European journal of anaesthesiology, 2012-05, Vol.29 (5), p.229-234
issn 0265-0215
1365-2346
language eng
recordid cdi_proquest_miscellaneous_1008825575
source MEDLINE; Journals@Ovid Complete
subjects Anesthesia, Inhalation - adverse effects
Anesthesia, Inhalation - instrumentation
Anesthetics, Inhalation - adverse effects
Decontamination - methods
Disease Susceptibility
Disposable Equipment
Equipment Contamination - prevention & control
Equipment Design
Hospitals, University
Hot Temperature
Humans
Ireland
Malignant Hyperthermia - etiology
Malignant Hyperthermia - prevention & control
Methyl Ethers - adverse effects
Respiration, Artificial - adverse effects
Respiration, Artificial - instrumentation
Risk Assessment
Risk Factors
Sterilization - methods
Time Factors
title Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T05%3A35%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preparation%20of%20the%20Drager%20Fabius%20CE%20and%20Drager%20Zeus%20anaesthetic%20machines%20for%20patients%20susceptible%20to%20malignant%20hyperthermia&rft.jtitle=European%20journal%20of%20anaesthesiology&rft.au=Shanahan,%20Hiliary&rft.date=2012-05&rft.volume=29&rft.issue=5&rft.spage=229&rft.epage=234&rft.pages=229-234&rft.issn=0265-0215&rft.eissn=1365-2346&rft_id=info:doi/10.1097/EJA.0b013e328351b521&rft_dat=%3Cproquest_cross%3E1008825575%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1008825575&rft_id=info:pmid/22388705&rfr_iscdi=true